These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 23722456

  • 1. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E, Zschaeck C, Gonzalez M, Mato T, Rodrigañez L, Barona R, Sanz R.
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 6. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease.
    Martin-Sanz E, Esteban-Sanchez J, Rodrigañez-Riesco L, Sanz-Fernández R.
    Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741
    [Abstract] [Full Text] [Related]

  • 7. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 8. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 9. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
    Weckel A, Marx M, Esteve-Fraysse MJ.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
    [Abstract] [Full Text] [Related]

  • 10. The use of electrocochleography to monitor the response of Ménière's disease patients to intratympanic steroids.
    Martin-Sanz E, Luzardo CZ, Riesco LR, Patino TM, Sanz R.
    Acta Otolaryngol; 2013 Nov; 133(11):1158-64. PubMed ID: 24125187
    [Abstract] [Full Text] [Related]

  • 11. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM, Keyser JS, Stallworth C, McElveen JT.
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [Abstract] [Full Text] [Related]

  • 12. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
    Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG.
    Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease.
    Lambert PR, Nguyen S, Maxwell KS, Tucci DL, Lustig LR, Fletcher M, Bear M, Lebel C.
    Otol Neurotol; 2012 Sep; 33(7):1257-65. PubMed ID: 22858715
    [Abstract] [Full Text] [Related]

  • 14. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF, Richey PA, Wan JY, Stevens SR.
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
    De Stefano A, Dispenza F, De Donato G, Caruso A, Taibah A, Sanna M.
    Am J Otolaryngol; 2007 Jan; 28(5):289-93. PubMed ID: 17826528
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
    Beyea JA, Instrum RS, Agrawal SK, Parnes LS.
    Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 19. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 20. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K, Ata N.
    Am J Otolaryngol; 2019 Dec; 40(5):711-714. PubMed ID: 31262549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.